Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

DBV Technologies SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

DBV TECHNOLOGIES SA (DBVT=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

06 Feb 2016 Pechala's Reports 2 $25.00

DBV TECHNOLOGIES SA - TERMINATION OF COVERAGE

Edison Investment Research is terminating coverage on DBV Technologies SA (DBV). Please note you should no longer rely on any...

01 Feb 2016 Edison Investment Research 1 $10.00

Wright Investors Service Comprehensive Report for Dbv Technologies

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

29 Jan 2016 Wright Reports 55 $75.00

DBV Technologies S.A. (DBV) - Financial Analysis Review

DBV Technologies S.A. (DBV) - Financial Analysis Review Summary DBV Technologies S.A. (DBV) is a biopharmaceutical company th...

21 Jan 2016 GlobalData 53 $300.00

DBV TECHNOLOGIES: ADR UPDATE - ENLARGED PHASE III PEPITES STUDY STARTS

DBV has now started the Phase III Viaskin Peanut trial (PEPITES), which has been enlarged to meet patient and investigator de...

09 Dec 2015 Edison Investment Research 5 $10.00

DBV TECHNOLOGIES - ENLARGED PHASE III PEPITES STUDY STARTS

DBV has now started the Phase III Viaskin Peanut trial (PEPITES), which has been enlarged to meet patient and investigator de...

09 Dec 2015 Edison Investment Research 5 $10.00

DBV Technologies S.A. (DBV) - Financial Analysis Review

DBV Technologies S.A. (DBV) - Financial Analysis Review Summary DBV Technologies S.A. (DBV) is a biopharmaceutical company th...

02 Dec 2015 GlobalData 56 $300.00

Interview with the Co-Founder, Chairman and CEO and the COO: DBV Technologies S.A. (NASDAQ:DBVT)

23 Oct 2015 Wall Street Transcript ,The 5 $50.00

ValuEngine Industry Report for Medical-Biomed/Genetics(DBVT)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

26 Aug 2015 ValuEngine, Inc. 10 $49.00